VIVUS Inc (VVUS)

2.79 -0.09  -3.12% NASDAQ Nov 21, 16:59 Delayed 2m USD

VIVUS Research and Development Expense (Quarterly):

3.266M for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 3.266M
June 30, 2019 2.352M
March 31, 2019 2.469M
Dec. 31, 2018 1.80M
Sept. 30, 2018 2.102M
June 30, 2018 2.042M
March 31, 2018 1.403M
Dec. 31, 2017 1.204M
Sept. 30, 2017 0.865M
June 30, 2017 1.014M
March 31, 2017 2.18M
Dec. 31, 2016 1.771M
Sept. 30, 2016 1.696M
June 30, 2016 1.096M
March 31, 2016 1.029M
Dec. 31, 2015 3.277M
Sept. 30, 2015 1.532M
June 30, 2015 2.599M
March 31, 2015 2.694M
Dec. 31, 2014 2.71M
Sept. 30, 2014 2.574M
June 30, 2014 4.086M
March 31, 2014 4.423M
Dec. 31, 2013 4.994M
Sept. 30, 2013 8.405M
   
June 30, 2013 9.232M
March 31, 2013 7.046M
Dec. 31, 2012 7.758M
Sept. 30, 2012 9.30M
June 30, 2012 8.873M
March 31, 2012 6.291M
Dec. 31, 2011 5.351M
Sept. 30, 2011 3.738M
June 30, 2011 11.04M
March 31, 2011 4.48M
Dec. 31, 2010 6.093M
Sept. 30, 2010 10.09M
June 30, 2010 13.58M
March 31, 2010 10.21M
Dec. 31, 2009 13.54M
Sept. 30, 2009 17.15M
June 30, 2009 20.26M
March 31, 2009 20.07M
Dec. 31, 2008 22.70M
Sept. 30, 2008 15.59M
June 30, 2008 15.34M
March 31, 2008 23.37M
Dec. 31, 2007 11.07M
Sept. 30, 2007 8.644M
June 30, 2007 3.955M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Advertisement

Research and Development Expense (Quarterly) Benchmarks

Benchmarks
Assertio Therapeutics Inc 1.476M
Synlogic Inc 10.56M
Soliton Inc 0.7843M

Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 0.865M Sep 2017
Maximum 3.277M Dec 2015
Average 1.955M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.